Immunological Targets of Biologic Drugs in Allergic Skin Diseases in Children
Atopic dermatitis and urticaria are two invalidating skin disorders that are very common in children. Recent advances in the understanding of their specific intracellular molecular pathways have permitted the development of precise biological molecules, targeting inflammatory mediators and arresting...
Guardado en:
Autores principales: | Paola Di Filippo, Daniele Russo, Marina Attanasi, Sabrina Di Pillo, Francesco Chiarelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a436256ab94e4fc586001026c3d6a310 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Basal serum cortisol and adrenocorticotropic hormone levels in patients with atopic dermatitis
por: Zohreh Tehranchinia, et al.
Publicado: (2017) -
Angiogenesis in Chronic Inflammatory Skin Disorders
por: Hyun Ji Lee, et al.
Publicado: (2021) -
Gardenia jasminoides extract ameliorates DfE-induced atopic dermatitis in mice through restoration of barrier function and T-helper 2-mediated immune response
por: Sun Haeng Park, et al.
Publicado: (2022) -
Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
por: Amal Ahmed Mohamed, et al.
Publicado: (2021) -
Increased Frequency of CTLA-4 and PD-1 Expressing Regulatory T Cells and Basophils With an Activating Profile in Infants With Moderate-to-Severe Atopic Dermatitis Hypersensitized to Food Allergens
por: Agurtzane Bilbao, et al.
Publicado: (2021)